BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.7921
-0.0979 (-11.00%)
At close: Aug 18, 2026, 4:00 PM EDT
0.8105
+0.0184 (2.32%)
After-hours: Aug 18, 2026, 7:48 PM EDT
BioXcel Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.84 | 28.42 | 29.85 | 65.22 | 193.73 | 232.97 |
Cash & Short-Term Investments | 12.84 | 28.42 | 29.85 | 65.22 | 193.73 | 232.97 |
Cash Growth | -26.35% | -4.82% | -54.23% | -66.33% | -16.84% | 9.31% |
Accounts Receivable | 0.08 | 0.23 | 0.13 | 0.07 | 0.25 | - |
Receivables | 0.08 | 0.23 | 0.13 | 0.07 | 0.25 | - |
Inventory | 0.48 | 0.72 | 0.68 | 1.99 | 1.99 | - |
Prepaid Expenses | 3.07 | 4.03 | 5.29 | 2.78 | 3.07 | 2.89 |
Restricted Cash | 0.96 | 0.34 | - | - | - | - |
Other Current Assets | 11.26 | 10.95 | 1.44 | 2.08 | 3.84 | 0.96 |
Total Current Assets | 28.7 | 44.69 | 37.39 | 72.14 | 202.87 | 236.81 |
Property, Plant & Equipment | 0.1 | 0.23 | 0.86 | 1.47 | 2.06 | 2.54 |
Other Long-Term Assets | - | - | 0.09 | 0.09 | 0.93 | 0.09 |
Total Assets | 28.8 | 44.92 | 38.34 | 73.7 | 205.85 | 239.44 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 18.78 | 14.7 | 15.99 | 13.65 | 10.23 | 4.68 |
Accrued Expenses | 3.92 | 4.45 | 5.78 | 13.15 | 22.18 | 11.39 |
Current Portion of Long-Term Debt | 104.45 | 24.93 | - | - | - | - |
Current Portion of Leases | - | 0.07 | - | - | - | - |
Current Income Taxes Payable | - | 0.03 | 0.09 | 0.12 | 0.08 | 0.3 |
Other Current Liabilities | 9.99 | 9.75 | 0.37 | 0.35 | 0.4 | 0.29 |
Total Current Liabilities | 137.15 | 53.93 | 22.23 | 27.27 | 32.9 | 16.67 |
Long-Term Debt | - | 84.66 | 102.51 | 100.6 | 93.05 | - |
Long-Term Leases | - | - | 0.07 | 0.44 | 0.79 | 1.11 |
Other Long-Term Liabilities | 7.11 | 1.79 | 6.63 | 1.91 | 2.34 | - |
Total Liabilities | 144.26 | 140.38 | 131.44 | 130.21 | 129.08 | 17.77 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.08 | 0.05 | 0.03 | 0.03 | 0.03 |
Additional Paid-In Capital | 632.01 | 624.56 | 557.05 | 534.06 | 488.29 | 467.43 |
Retained Earnings | -747.5 | -720.09 | -650.2 | -590.6 | -411.55 | -245.79 |
Shareholders' Equity | -115.46 | -95.46 | -93.1 | -56.51 | 76.78 | 221.67 |
Total Liabilities & Equity | 28.8 | 44.92 | 38.34 | 73.7 | 205.85 | 239.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 104.45 | 109.66 | 102.57 | 101.04 | 93.84 | 1.11 |
Net Cash (Debt) | -91.61 | -81.24 | -72.72 | -35.82 | 99.89 | 231.86 |
Net Cash Growth | - | - | - | - | -56.92% | 9.51% |
Net Cash Per Share | -4.07 | -6.65 | -28.69 | -19.67 | 57.05 | 140.67 |
Filing Date Shares Outstanding | 31.31 | 27.07 | 5.49 | 1.91 | 1.81 | 1.75 |
Total Common Shares Outstanding | 31.31 | 22.33 | 3.1 | 1.87 | 1.76 | 1.75 |
Working Capital | -108.45 | -9.24 | 15.16 | 44.88 | 169.97 | 220.15 |
Book Value Per Share | -3.69 | -4.28 | -30.01 | -30.21 | 43.64 | 126.76 |
Tangible Book Value | -115.46 | -95.46 | -93.1 | -56.51 | 76.78 | 221.67 |
Tangible Book Value Per Share | -3.69 | -4.28 | -30.01 | -30.21 | 43.64 | 126.76 |
Machinery | - | 0.78 | 0.78 | 0.78 | 0.79 | 0.74 |
Construction In Progress | - | - | - | - | - | 0.02 |
Leasehold Improvements | - | 1.2 | 1.2 | 1.2 | 1.18 | 1.13 |